Extension study demonstrates stable long-term safety, efficacy profiles for peficitinib medwireNews, 30 Aug 2019 30-08-2019 | Rheumatology | News | Article medwireNews: The Janus kinase (JAK) inhibitor peficitinib has demonstrated a…